A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease (Q24680126)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease
scientific article

    Statements

    A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease (English)
    0 references
    0 references
    0 references
    0 references
    W Reinisch
    0 references
    D W Hommes
    0 references
    G Van Assche
    0 references
    J-P Gendre
    0 references
    B Oldenburg
    0 references
    A Teml
    0 references
    K Geboes
    0 references
    H Ding
    0 references
    L Zhang
    0 references
    M Tang
    0 references
    M Cheng
    0 references
    S J H van Deventer
    0 references
    T Pearce
    0 references
    August 2006
    0 references
    0 references
    55
    0 references
    8
    0 references
    1138-44
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit